<?xml version="1.0" encoding="UTF-8"?>
<p>Next, to assess pre-existing DENV Ab responses and their contribution to early ZIKV control, depletion of DENV-2 specific Abs in serum from day 7 p.i. was performed, followed by confirmation by measuring DENV-IgG binding using an ELISA (
 <xref ref-type="fig" rid="pntd.0008285.g004">Fig 4A</xref>). Due to limited amount of serum, only 4 animals from the DENV 12M group and 2 animals from the na√Øve group were chosen for serum depletions. Depletions were more than 98% successful for all tested sera (
 <xref ref-type="fig" rid="pntd.0008285.g004">Fig 4B</xref>). As expected, neutralization against DENV-2 was affected by the removal of type-specific Abs (
 <xref ref-type="fig" rid="pntd.0008285.g004">Fig 4C</xref>). On the other hand, ZIKV neutralization remained unchanged after depletion of DENV-2 Abs, indicating that ZIKV-specific Abs make up most of the neutralizing force early during ZIKV infection regardless of any pre-existing DENV immunity (
 <xref ref-type="fig" rid="pntd.0008285.g004">Fig 4D</xref>).
</p>
